Tetsuo Takehara

72PUBLICATIONS
136CO-AUTHORS
Predictive and prognostic markersBehavioural epidemiologyCardiology (incl. cardiovascular diseases)Cancer diagnosisMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Aug 02, 2026
Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All-Cause Mortality After SVR in Advanced Chronic Hepatitis C.

|Apr 30, 2026
Nationwide Engagement in an Interdisciplinary eLearning Program on Alcohol Dependence in Japan.

|Mar 24, 2026
Impact of Treatment Response to Anticoagulant Therapy on Liver-Related Events in Patients With Cirrhosis and Portal Vein Thrombosis.

Atsushi Maeda, Yuki Tahata, Hayato Hikita

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

|Nov 18, 2025
The Nara Declaration: A New Collaborative Flow for Chronic Liver Disease Between Primary Care Physicians and Gastroenterologists/Hepatologists.

Takumi Kawaguchi, Hitoshi Yoshiji, Satoshi Mochida

|Oct 31, 2025
Long-term changes in hepatic reserve and prognosis after direct-acting antiviral treatment in patients with hepatitis C virus-related decompensated cirrhosis: a five-year follow-up study of a Japanese phase 3 trial.

Yuki Tahata, Hayato Hikita, Akinobu Takaki

Pageof 12

Frequent Collaborators

24 joint publications

Hayato Hikita

24 joint publications

Takahiro Kodama

23 joint publications

Ryotaro Sakamori

8 joint publications

Kazuyoshi Ohkawa